版本:
中国

BRIEF-Orexigen Therapeutics announces new drug submission for Contrave in Canada

April 25 Orexigen Therapeutics Inc

* Orexigen Therapeutics Inc announces new drug submission for Contrave© in canada

* Orexigen Therapeutics - if approved, Valeant will market and distribute Contrave in Canada as part of its distributorship agreement with Orexigen Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐